=== SUMMARY ===
- The post discusses Boston Scientific (BSX) after a rough Q1, with the author considering the stock fairly valued but not cheap.
- The author seeks input on an appropriate cheap price to buy 2028 LEAPS, expressing concern about “catching a falling knife.”
- Quality assessment: This is speculation/opinion-seeking, not a well-researched deep dive; limited data or analysis provided.
=== SENTIMENT ===
NEUTRAL
=== TRADE IDEAS ===
No actionable trade ideas in this post.